DI SARNO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.418
AS - Asia 1.386
EU - Europa 963
SA - Sud America 188
AF - Africa 33
OC - Oceania 1
Totale 3.989
Nazione #
US - Stati Uniti d'America 1.366
SG - Singapore 660
RU - Federazione Russa 526
CN - Cina 273
VN - Vietnam 233
BR - Brasile 140
HK - Hong Kong 111
DE - Germania 74
NL - Olanda 67
IT - Italia 60
FI - Finlandia 50
FR - Francia 37
IE - Irlanda 36
SE - Svezia 33
GB - Regno Unito 28
CA - Canada 26
IN - India 23
MX - Messico 21
AR - Argentina 18
UA - Ucraina 17
JP - Giappone 14
ZA - Sudafrica 11
IQ - Iraq 10
EC - Ecuador 9
PL - Polonia 9
TR - Turchia 9
PK - Pakistan 8
BD - Bangladesh 7
CI - Costa d'Avorio 7
CO - Colombia 7
ID - Indonesia 6
TH - Thailandia 6
ES - Italia 5
BO - Bolivia 4
CL - Cile 4
CZ - Repubblica Ceca 4
KR - Corea 4
MA - Marocco 4
UZ - Uzbekistan 4
AT - Austria 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LV - Lettonia 2
NO - Norvegia 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MW - Malawi 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 3.989
Città #
Singapore 329
San Jose 224
Chandler 179
Hong Kong 110
Moscow 101
Beijing 95
Ashburn 88
Ho Chi Minh City 78
Amsterdam 63
Millbury 56
The Dalles 50
Hanoi 43
Jacksonville 42
Nanjing 42
Los Angeles 39
Santa Clara 38
Princeton 35
Lauterbourg 30
Wilmington 24
New York 21
Munich 20
São Paulo 19
Buffalo 15
Da Nang 14
Mexico City 14
Naples 13
Nanchang 12
Redondo Beach 12
Tokyo 12
Ann Arbor 11
Dallas 11
Norwalk 11
Helsinki 9
Montreal 9
Orem 9
Warsaw 9
Boston 8
Brooklyn 8
Chennai 8
Haiphong 8
Turku 8
Chicago 7
Ottawa 7
Phoenix 7
Shenyang 7
Denver 6
Houston 6
London 6
Milan 6
Rio de Janeiro 6
Seattle 6
Belo Horizonte 5
Council Bluffs 5
Kunming 5
San Francisco 5
Tianjin 5
Atlanta 4
Bangkok 4
Brasília 4
Changsha 4
Erbil 4
Falkenstein 4
Frankfurt am Main 4
Guangzhou 4
Jiaxing 4
Johannesburg 4
Lahore 4
Manchester 4
Ningbo 4
Pune 4
Quito 4
Toronto 4
Camaçari 3
Des Moines 3
Düsseldorf 3
Hebei 3
Hải Dương 3
Jinan 3
Kuala Lumpur 3
Mumbai 3
Querétaro 3
Quận Một 3
Recife 3
San Sebastiano al Vesuvio 3
Secaucus 3
Tashkent 3
Tel Aviv 3
Torino 3
Araruama 2
Banhā 2
Bari 2
Boardman 2
Brno 2
Can Tho 2
Canoas 2
Cape Town 2
Changchun 2
Charlotte 2
Chengdu 2
Columbus 2
Totale 2.152
Nome #
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 165
Hepatic arterial embolization in patients with neuroendocrine tumors. 158
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 152
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 151
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 149
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 145
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 138
Prediction of efficacy of octreotide therapy in patients with acromegaly 135
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 132
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 131
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up 130
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 128
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 125
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 125
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases 124
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 123
CV 205-502 treatment in therapy-resistant acromegalic patients 120
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 119
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia 116
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 114
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 112
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 103
Effect of different dopaminergic agents in the treatment of acromegaly 103
Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results 102
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 100
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 100
Hyperprolactinemia in men: clinical and biochemical features and response to treatment 99
Prostatic hyperplasia: an unknown feature of acromegaly 88
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly 85
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 83
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 82
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline 78
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 75
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 72
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitarytumor coincident with GNAS gene mutation. 64
Totale 4.026
Categoria #
all - tutte 13.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022226 1 0 0 1 5 22 2 6 38 26 40 85
2022/2023378 37 37 16 33 46 39 1 34 52 64 11 8
2023/2024133 9 32 18 7 2 8 6 13 0 1 19 18
2024/20251.013 42 29 1 10 19 52 124 72 47 105 432 80
2025/20261.961 217 99 172 180 401 83 247 114 229 153 55 11
Totale 4.026